DNA Methylation in Prostate Cancer: Clinical Implications and Potential Applications
ABSTRACT Background Prostate cancer is a common cancer with a variable prognosis. Its management is currently guided by histological and biological markers such as the Gleason score and PSA. Developments in molecular biology are now making it possible to identify new targets for better classificatio...
Saved in:
Main Authors: | Romane Muletier, Céline Bourgne, Laurent Guy, Aurore Dougé |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70528 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
by: Ian López-Cruz, et al.
Published: (2025-01-01) -
The technology landscape for detection of DNA methylation in cancer liquid biopsies
by: Isabelle Neefs, et al.
Published: (2025-12-01) -
Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk
by: Fahad M. Aldakheel, et al.
Published: (2025-02-01) -
Pre-operative DNA methylation marks as predictors of weight loss outcomes after sleeve gastrectomy
by: Guillermo Paz-López, et al.
Published: (2025-02-01) -
Research progress of DNA methylation in the screening of cervical cancer and precancerous lesions
by: Yunge Wang, et al.
Published: (2025-01-01)